Stoke Therapeutics Inc is a biotechnology company focused on the development of RNA-based treatments for severe genetic diseases. The company’s technology aims to precisely upregulate proteins that are deficient due to genetic mutations.
No data available
Are you interested in the impact of this stock or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!